Clintas-CL Vaginal Suppository

Introduction

Clintas-CL is a prescription medication that combines two active ingredients: Clindamycin and Clotrimazole. It is primarily used for the treatment of vaginal infections caused by certain types of bacteria and yeast.

Uses

Clintas-CL is prescribed to treat vaginal infections such as bacterial vaginosis and vaginal yeast infections. Bacterial vaginosis is caused by an imbalance of bacteria in the vagina, while vaginal yeast infections are caused by an overgrowth of yeast. This medication helps to eliminate the bacteria and yeast that cause these infections, providing relief from symptoms such as itching, discharge, and odor.

Dosage and Administration

The recommended dosage of Clintas-CL is one suppository inserted into the vagina once daily, usually at bedtime, for a specified duration as prescribed by your healthcare provider. Follow the instructions provided by your healthcare provider and complete the full course of treatment, even if symptoms improve before the treatment is finished.

To use the suppository, wash your hands thoroughly and remove the suppository from its packaging. Lie on your back with your knees bent, gently insert the suppository into the vagina using the applicator provided, and push it in as far as it will comfortably go. Dispose of the applicator after use. Wash your hands again after application.

Mechanism of Action

Clintas-CL combines two active ingredients, Clindamycin and Clotrimazole, which work together to combat vaginal infections. Clindamycin is an antibiotic that inhibits the growth of bacteria by interfering with their protein synthesis. Clotrimazole is an antifungal medication that works by disrupting the cell membrane of yeast, causing it to break down and ultimately killing the yeast.

By targeting both bacteria and yeast, this medication addresses the underlying causes of vaginal infections, helping to restore the balance of microorganisms in the vagina and alleviate symptoms.

Side Effects

Common side effects may include vaginal itching, irritation, or a burning sensation. These side effects are usually mild and temporary.

However, if you experience any severe or persistent side effects such as rash, swelling, or difficulty breathing, seek immediate medical attention. These could be signs of a serious allergic reaction and require prompt medical intervention.

Drug Interactions

Clintas-CL may interact with certain medications or substances. Inform your healthcare provider about all the medications, supplements, or herbal products you are taking before starting treatment with Clintas-CL.

Some medications may interact with Clindamycin, one of the active ingredients in Clintas-CL. These include certain antibiotics, such as erythromycin, as well as medications that may prolong the QT interval, such as certain antiarrhythmic drugs. Your healthcare provider will evaluate the potential interactions and adjust your treatment plan accordingly.

Precautions

Before using Clintas-CL, inform your healthcare provider about any known allergies or sensitivities to Clindamycin, Clotrimazole, or any other ingredients in the medication. This will help prevent the occurrence of an allergic reaction.

Additionally, let your healthcare provider know about any other medications you are currently taking, as well as any medical conditions you have, including liver or kidney disease. This information will help your healthcare provider determine if Clintas-CL is suitable for you and if any adjustments to the dosage or treatment plan are necessary.

Storage

Clintas-CL should be stored at room temperature, away from moisture and heat. Keep the suppositories in their original packaging until ready to use. Do not freeze the medication.

Patient Tips

• Follow the prescribed dosage and treatment duration as instructed by your healthcare provider, even if symptoms improve before the treatment is finished.
• Avoid sexual intercourse while using Clintas-CL, as it may interfere with the effectiveness of the medication or cause discomfort.
• If you have any questions or concerns about the use of Clintas-CL, do not hesitate to reach out to your healthcare provider for clarification.
• If symptoms worsen or do not improve after completing the full course of treatment, consult your healthcare provider for further evaluation and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Clotrimazole: medicine used to treat fungal skin infections (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
• Clindamycin + Benzoyl Peroxide 10mg/g + 50mg/g Gel (Health Professionals SmPC) Available at:
• Clindamycin (Drugs.com) [Accessed 19 Jun. 2024] (online) Available at:
• adapalene 0.15 %-benzoyl peroxide 3.1 %-clindamycin 1.2 % topical gel (RX) [Accessed 0 Jun. 2024] (online) Available at:
• Clindamycin Vaginal (MedlinePlus) [Accessed 12 Jun. 2024] (online) Available at:
• Donaldson M, Goodchild JH. Is clindamycin dangerous? Gen Dent. 2017 Jul-Aug;65(4):12-15. [Accessed 19 Jun. 2024] Available at: